Dr. Sharon H. Jaycox is the Director of Fatty Liver Disease at the Global Liver Institute, bringing over a decade in public health leadership and experience in metabolic health, clinical research, and advancing health equity. Her work has included leading clinical trial operations, implementing community-based health initiatives, and building partnerships to improve representation in research.

Dr. Jaycox is a strategic and mission-driven leader dedicated to advancing initiatives in fatty liver disease through effective program management, stakeholder engagement, and research-driven solutions.

With a deep understanding of metabolics, hepatology, and oncology trends, Dr. Jaycox stays at the forefront of developments in liver fibrosis, inflammation, and cirrhosis ensuring that evolving research informs impactful strategies.

Recognized for her expertise in stakeholder engagement, Dr Jaycox cultivates meaningful relationships within the fatty liver disease domain, empowering patients who participate in advocacy efforts such as GLI’s Advanced Advocacy Academy (A3). With a commitment to fostering collaboration, Dr. Jaycox unites diverse stakeholders to drive progress in the field.

A skilled leader with a visionary approach, Dr. Jaycox brings expertise, collaboration, and innovation to the field, shaping meaningful advancements in fatty liver disease advocacy and research.